Ad Banner Web

Synopsis: Heranba Industries jumps 9% after launching Fentaamine bio-stimulant and MycoHil biofertilizer in Hyderabad, targeting crop stress relief and soil health under Vision 2026 expansion.

Heranba Industries Limited made a bold move on Thursday. The agrochemical company entered the crop nutrition segment with two new products. Investors responded with strong buying interest.

Ad Banner Mobile

Heranba Industries‘s Limited’s stock, with a market capitalisation of Rs. 800 crores, rose to Rs. 208.70, up of 9.3 percent from its previous closing price of Rs. 190.99. Furthermore, the stock over the past year has given a negative return of 15.4 percent.

At a launch event in Hyderabad, the company introduced Fentaamine and MycoHil. Both products target Indian farmers directly. Fentaamine is a bio-stimulant. It helps plants handle stress better and boosts crop yield. MycoHil, on the other hand, is a biofertilizer. It improves how plants absorb nutrients and supports healthier soil.

Delta Exchange banner

Heranba developed both products with a leading American multinational company. The collaboration blends global research with local manufacturing strength.

The launch is part of Heranba’s larger Vision 2026 plan. The company is chasing a total turnover of Rs. 2,500 crore in the current fiscal year. That is an ambitious number and management is clearly pushing hard to reach it.

tradebrains portal smallcase

Managing Director R. K. Shetty said the crop nutrition market is growing at over 15% annually. “Our entry into this space is a natural strategic progression,” he said. The company aims to scale this segment significantly over the next three years.

Heranba is not stopping at India. The company plans to expand into 80-plus countries. It also intends to open a subsidiary in Dubai. This move will strengthen its reach across the Middle East and Africa.

The company already runs seven manufacturing facilities. It is also scaling up contract manufacturing operations. These steps aim to boost capacity and build brand value globally.

zerodha banner

To support this growth, Heranba is investing in several key areas. These include hiring new talent, strengthening its sales network, and deepening farmer engagement at the ground level.

Channel partner development and global business expansion are also priorities. Together, these efforts form a clear foundation for long-term growth. Heranba is a listed manufacturer of synthetic pyrethroids. It operates across the full agrochemical value chain from raw materials to final formulations.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

  • : Author

    Financial analyst with over 1.5+ years of experience covering equity markets, cryptocurrencies, and IPOs, and has authored more than 1,600+ in-depth articles. His coverage spans publicly listed companies, crypto markets, geopolitical developments, and currency trends. In addition, he has led content development for cryptocurrency platforms, creating educational material on blockchain, DeFi, and NFTs.

× Ad Banner desktop Advertisement